Aardvark Therapeutics, Inc.·4

Sep 10, 5:36 PM ET

Sun Nelson 4

4 · Aardvark Therapeutics, Inc. · Filed Sep 10, 2025

Insider Transaction Report

Form 4
Period: 2025-09-09
Sun Nelson
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-09-09$8.07/sh+6,000$48,440105,484 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.00 to $8.20 per share, inclusive. The reporting person undertakes to provide Aardvark Therapeutics, Inc. ("Aardvark"), any security holder of Aardvark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4